救护车对老年人摔倒的反应:一个系统的审查
Imogen M Gunson1,2, Chloé Barley2, Andy Rosser2
1Faculty of Medicine & Health Sciences, Keele University, Newcastle-under-Lyme, UK.
Age and ageing
|August 17, 2025
概括
针对老年人摔倒的结构化救护照顾改善了结果. 实施跌倒路径可以提高患者的护理,但护理人员的采用和指南的相关性需要进一步研究以获得更广泛的应用.
科学领域:
- 老年学是一门学科.
- 紧急医疗服务 紧急医疗服务
- 公共卫生 公共卫生
背景情况:
- 跌倒是老年人的一个重大问题,约占紧急救护车呼叫的10%.
- 老年人摔倒的结构化管理可能会改善患者的治疗结果和医疗保健的成本效益.
研究的目的:
- 综合有关救护车照顾老年人摔倒的证据.
- 评估这些干预措施对患者结果的影响.
主要方法:
- 在多个数据库 (CINAHL,MEDLINE,Embase,HMIC,Web of Science,AMBER) 进行了全面的文献搜索,没有日期限制.
- 在使用Joanna Briggs Institute工具进行质量评估后,包括随机集群试验和队列研究在内的9项同行评审研究被纳入.
- 数据使用 PRISMA 准则的叙事合成进行了合成.
主要成果:
- 用特定于季节的决策工具或转诊途径管理的患者的住院时间减少,获得社区医疗保健的机会增加.
- 尽管现有的秋季应急计划取得了积极的成果,但护理人员的接受程度不佳限制了广泛的影响.
- 观察到遵守国家指导方针,患者的社会因素,如独自生活,影响了偏差.
结论:
- 实施的下降途径表明患者的治疗结果有所改善,尽管环境特定的因素影响了成功实施.
- 救护车工作人员通常遵循指导方针,但它们与当代呈现和治疗方法的当前相关性需要评估.
- 需要进行进一步的研究,以开发针对老年人的救护车式倒护理的可通用方法.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


